NVCR NovoCure Limited gains 35% May 15, 2018
Markets a wearable electric field device for treating glioblastoma brain cancer.http://www.priceseries.com/trade/NVCR-NovoCure-Limited-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2018041020180515.html